Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Additive Innovations is a specialized technology company focused on the application of additive manufacturing (3D printing) within the pharmaceutical, nutraceutical, and food industries. Founded in 2022 by former executives of The ExOne Company, the firm utilizes its proprietary AI Forge binder jetting platform to develop innovative oral dosage forms, including controlled-release tablets and multi-material polypills. The company provides hardware, software, and process development services to enable decentralized, on-demand manufacturing of personalized medicines. By leveraging food-grade certified technology, Additive Innovations aims to improve dosage accuracy and design flexibility for complex therapeutic regimens.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Additive Innovations.